Schedule 13G ownership disclosure

Oruka Therapeutics Inc

Common Stock, par value $0.001 per share · CUSIP: 687604108

Event date: 2025-02-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Venrock Healthcare Capital Partners III, L.P.

    Shares: 4,148,428.00 · Class: 11.1%

  • VHCP Co-Investment Holdings III, LLC

    Shares: 4,148,428.00 · Class: 11.1%

  • Venrock Healthcare Capital Partners EG, L.P.

    Shares: 4,148,428.00 · Class: 11.1%

  • VHCP Management III, LLC

    Shares: 4,148,428.00 · Class: 11.1%

  • VHCP Management EG, LLC

    Shares: 4,148,428.00 · Class: 11.1%

  • Nimish Shah

    Shares: 4,148,428.00 · Class: 11.1%

  • Bong Y Koh

    Shares: 4,148,428.00 · Class: 11.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-005913
Form type
SCHEDULE 13G/A
Filer
Oruka Therapeutics, Inc.
CIK
CIK 907654
Filed
Feb 27, 2025
Reporting period
Feb 10, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub